Astera Labs ALAB
$180.35 −$31.25 (-14.77%)
Market closed · Nov 22, 5:50 am ET · Last extended-hours $186.20 +3.24%
Open$203.64
Prev close$211.60
Day range$176.78 – $205.93
Volume7.97M
Market cap$31.52B
P/E (TTM)71.3
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$584.90M+153.7% YoY
Operating profit$179.06M+223.2% YoY
Net profit$182.94M+100.8% YoY
Diluted EPS$0.99+98.0% YoY
Free cash flow$133.89M+103.2% YoY
Operating cash flow$179.20M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin73.9%
Operating margin25.5%
Net margin29.6%
Return on equity28.2%
Return on assets24.9%
Return on invested capital26.4%
Current ratio8.03
Liabilities / assets13.1%
Cash & investments$1.38B
Net cash (debt)$1.38B
Free cash flow / sales22.1%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $584.90M | $392.40M | $308.36M | $852.53M | $270.58M |
| Total Operating Revenue | $584.90M | $392.40M | $308.36M | $852.53M | $270.58M |
| Cost of Revenue | $162.15M | $104.83M | $73.22M | $207.26M | $66.11M |
| Gross Profit | $422.75M | $287.57M | $235.14M | $645.26M | $204.48M |
| Operating Expense | $243.70M | $198.32M | $173.31M | $471.84M | $137.52M |
| Selling and Admin Expenses | $72.74M | $62.42M | $47.67M | $167.84M | $43.73M |
| -Selling & Marketing Expense | $37.43M | $26.37M | $21.90M | $79.77M | $20.10M |
| -General & Admin Expense | $35.31M | $36.05M | $25.78M | $88.07M | $23.62M |
| Research & Development | $170.96M | $135.90M | $125.63M | $304.00M | $93.79M |
| Operating Profit | $179.06M | $89.25M | $61.83M | $173.42M | $66.96M |
| Net Non-Operating Interest Income (Expense) | $12.97M | $13.58M | $11.58M | $44.73M | $11.96M |
| Non-Operating Interest Income | $12.97M | $13.58M | $11.58M | $44.73M | $11.96M |
| Pretax Profit | $192.03M | $102.83M | $73.41M | $218.15M | $78.92M |
| Tax | $9.08M | -$50.26M | -$6.90M | -$981,000.00 | $33.93M |
| Net Profit | $182.94M | $153.09M | $80.31M | $219.13M | $44.98M |
| Profit from Continuing Operations | $182.94M | $153.09M | $80.31M | $219.13M | $44.98M |
| Net Income to Parent Company | $182.94M | $153.09M | $80.31M | $219.13M | $44.98M |
| Net Income to Common Stockholders | $182.94M | $153.09M | $80.31M | $219.13M | $44.98M |
| Basic EPS | $1.05 | $0.89 | $0.47 | $1.32 | $0.27 |
| Diluted EPS | $0.99 | $0.83 | $0.44 | $1.22 | $0.25 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $2.30B | $1.93B | $1.66B | $1.53B | $1.53B |
| Total Current Assets | $1.96B | $1.65B | $1.41B | $1.36B | $1.36B |
| Cash and Cash Equivalents & Short-Term Investments | $1.38B | $1.25B | $1.18B | $1.19B | $1.19B |
| -Cash and Cash Equivalents | $209.40M | $111.45M | $148.29M | $167.61M | $167.61M |
| -Short Term Investments | $1.17B | $1.14B | $1.04B | $1.02B | $1.02B |
| Receivables | $335.93M | $252.73M | $134.80M | $83.20M | $83.20M |
| -Accounts Receivable | $284.25M | $192.47M | $134.80M | $83.20M | $83.20M |
| -Taxes Receivable | $51.67M | $60.26M | – | – | – |
| Inventory | $200.89M | $113.78M | $60.16M | $58.98M | $58.98M |
| Other Current Assets | $40.16M | $32.43M | $33.51M | $31.03M | $31.03M |
| Total Non-Current Assets | $345.11M | $279.61M | $246.28M | $169.79M | $169.79M |
| Net PPE | $170.71M | $119.28M | $97.17M | $92.04M | $92.04M |
| -Gross PPE | $195.12M | $138.65M | $112.60M | $103.76M | $103.76M |
| -Accumulated Depreciation | -$24.40M | -$19.36M | -$15.43M | -$11.72M | -$11.72M |
| Goodwill and Other Intangible Assets | $91.56M | $91.56M | $87.73M | – | – |
| -Goodwill | $91.56M | $91.56M | $87.73M | – | – |
| Other Non-Current Assets | $82.84M | $68.77M | $61.38M | $77.76M | $77.76M |
| Total Liabilities | $300.87M | $205.80M | $165.27M | $168.19M | $168.19M |
| Total Current Liabilities | $243.58M | $164.31M | $125.04M | $133.04M | $133.04M |
| Payables | $96.83M | $53.93M | $55.82M | $42.36M | $42.36M |
| -Accounts Payable | $96.83M | $53.93M | $55.82M | $42.36M | $42.36M |
| Current Accrued Expenses | $32.09M | $24.58M | $9.20M | $7.63M | $7.63M |
| Other Current Liabilities | $51.92M | $43.55M | $37.26M | $32.39M | $32.39M |
| Total Non-Current Liabilities | $57.29M | $41.49M | $40.22M | $35.15M | $35.15M |
| Other Non-Current Liabilities | $57.29M | $41.49M | $40.22M | $35.15M | $35.15M |
| Total Equity | $2.00B | $1.73B | $1.49B | $1.36B | $1.36B |
| Stockholders' Equity | $2.00B | $1.73B | $1.49B | $1.36B | $1.36B |
| Capital Stock | $17,000.00 | $17,000.00 | $17,000.00 | $17,000.00 | $17,000.00 |
| -Common Stock | $17,000.00 | $17,000.00 | $17,000.00 | $17,000.00 | $17,000.00 |
| Additional Paid-In Capital | $1.59B | $1.49B | $1.40B | $1.35B | $1.35B |
| Retained Earnings | $426.68M | $243.74M | $90.65M | $10.34M | $10.34M |
| Gains/Losses Not Affecting Retained Earnings | -$13.19M | -$3.37M | -$780,000.00 | $4.31M | $4.31M |
| Short-Term Debt and Capital Lease Obligation | – | – | – | $4.15M | $4.15M |
| -Current Capital Lease Obligation | – | – | – | $4.15M | $4.15M |
| Current Deferred Liabilities | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $179.20M | $87.68M | $74.60M | $319.31M | $95.27M |
| Net cash flow from continuing operations | $179.20M | $87.68M | $74.60M | $319.31M | $95.27M |
| Net Income from Continuing Operations | $182.94M | $153.09M | $80.31M | $219.13M | $44.98M |
| Gain/Loss from Continuing Operations | $18.08M | $10.22M | $2.10M | $5.51M | $1.50M |
| Depreciation & Depletion & Amortization | $5.04M | $3.93M | $3.71M | $6.83M | $2.85M |
| Other Non-Cash Items | $7.56M | -$107,000.00 | -$136,000.00 | $1.69M | -$829,000.00 |
| Change in Working Capital | -$115.77M | -$142.46M | -$59.09M | -$65.96M | $7.05M |
| -Change in Receivables | -$91.78M | -$57.67M | -$51.79M | -$44.34M | -$40.25M |
| -Change in Inventory | -$93.05M | -$53.47M | $346,000.00 | -$12.95M | -$5.84M |
| -Change in Prepaid Assets | -$10.35M | -$55.31M | $13.89M | -$33.76M | $23.00M |
| -Change in Payables and Accrued Expense | $79.41M | $23.99M | -$21.54M | $29.96M | $35.02M |
| Net cash flow from investing | -$81.22M | -$131.56M | -$94.01M | -$241.47M | -$72.79M |
| Net Cash Flow from Continuing Investing Activities | -$81.22M | -$131.56M | -$94.01M | -$241.47M | -$72.79M |
| Net PPE Purchase and Sale | -$45.31M | -$20.47M | -$7.59M | -$37.54M | -$18.69M |
| Net Business Purchase and Sale | $0.00 | -$4.17M | -$65.05M | -$28.79M | -$28.79M |
| Net Investment Purchase and Sale | -$35.92M | -$106.93M | -$18.87M | -$174.64M | -$25.32M |
| Net Other Investing Changes | $0.00 | $0.00 | -$2.50M | -$500,000.00 | $0.00 |
| Financing Cash Flow | -$34,000.00 | $7.05M | $82,000.00 | $9.80M | $3.73M |
| Net Cash Flow from Continuing Financing Activities | -$34,000.00 | $7.05M | $82,000.00 | $9.80M | $3.73M |
| Proceeds from Stock Option Exercised | -$34,000.00 | $7.05M | $82,000.00 | $9.80M | $3.73M |
| Ending Cash Balance | $209.47M | $111.52M | $148.36M | $167.68M | $167.68M |
| Net Change in Cash | $97.94M | -$36.83M | -$19.33M | $87.64M | $26.20M |
| Beginning Cash Balance | $111.52M | $148.36M | $167.68M | $80.04M | $141.48M |
| Free Cash Flow | $133.89M | $67.21M | $67.01M | $281.76M | $76.58M |
| -Change in Other Current Liabilities | – | – | – | -$4.88M | -$1.53M |
| Net Common Stock Issuance | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on ALAB.
Sign in to join the discussion.